Back

Innovation in mitral regurgitation therapy: a head-to-head analysis of the transcatheter edge-to-edge repair devices

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in interventional cardiology (2) Mitral Valve Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Tatiana Pereira dos Santos

Centro Hospitalar E Universitario De Coimbra, Coimbra (Portugal)

7 More presentations in this session

Presentation thumbnail
Impact of etiology, age and left ventricular ejection fraction on 12-month mortality effects of transcatheter edge-to-edge repair vs. surgery: a meta-regression analysis
Doctor E. Mata (Creixomil, PT)
Abstract Slides Video
Presentation thumbnail
Comparing 30-day outcomes of transcatheter edge-to-edge repair vs surgery in mitral valve regurgitation: a meta-analysis of clinical trials and propensity-matched cohorts
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Aortic valve disease and its effect on clinical outcomes in mitral TEER patients
Doctor A. Silva (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Impact of baseline mitral regurgitation grade on clinical and echocardiographic outcomes following transcatheter edge-to-edge repair
Doctor A. Silva (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Unveiling the persistence of iatrogenic atrial septal defects after mitral transcatheter edge-to-edge repair
Doctor R. Fernandes (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in interventional cardiology (2)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Triclip versus Pascal for tricuspid transcatheter edge-to-edge repair: impact on right ventricle remodelling and clinical outcomes
thumbnail
Congress Presentation
Transcatheter mitral valve repair: 10-year experience from a Portuguese tertiary care center
thumbnail
Congress Presentation
A meta-analysis on 12-month efficacy outcomes of transcatheter mitral valve repair vs surgery on mitral regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources